IL89567A0 - Mutated hiv envelope protein - Google Patents

Mutated hiv envelope protein

Info

Publication number
IL89567A0
IL89567A0 IL89567A IL8956789A IL89567A0 IL 89567 A0 IL89567 A0 IL 89567A0 IL 89567 A IL89567 A IL 89567A IL 8956789 A IL8956789 A IL 8956789A IL 89567 A0 IL89567 A0 IL 89567A0
Authority
IL
Israel
Prior art keywords
envelope protein
hiv envelope
mutated hiv
mutated
protein
Prior art date
Application number
IL89567A
Other languages
English (en)
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of IL89567A0 publication Critical patent/IL89567A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL89567A 1988-03-28 1989-03-10 Mutated hiv envelope protein IL89567A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17400588A 1988-03-28 1988-03-28

Publications (1)

Publication Number Publication Date
IL89567A0 true IL89567A0 (en) 1989-09-10

Family

ID=22634418

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89567A IL89567A0 (en) 1988-03-28 1989-03-10 Mutated hiv envelope protein

Country Status (5)

Country Link
EP (1) EP0335635A1 (xx)
JP (1) JPH029372A (xx)
AU (1) AU3170089A (xx)
DK (1) DK149589A (xx)
IL (1) IL89567A0 (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
DE69111440T2 (de) * 1990-04-03 1996-03-28 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
WO1991019795A1 (en) * 1990-06-19 1991-12-26 Immuvax Nonpathogenic variant virus
KR100194079B1 (ko) * 1990-09-28 1999-06-15 장 스테판느 Hiv 감염 예방 또는 치료용 제약학적 조성물 및 이의 제조방법
GB9106048D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccines
CA2093427C (en) * 1990-10-17 2008-01-15 Marvin S. Reitz, Jr. Molecular clones of hiv-1 and uses thereof
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
NZ249808A (en) * 1992-03-27 1996-09-25 Int Flower Dev Pty Ltd Genetic sequence encoding flavonoid pathway enzymes and their uses
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
WO1994016081A1 (de) * 1993-01-16 1994-07-21 Manfred Schawaller Verfahren zur gewinnung nativer domänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
US5864027A (en) * 1993-06-07 1999-01-26 Genentech, Inc. HIV envelope polypeptides
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
EP2388015A1 (en) * 2000-03-02 2011-11-23 Emory University DNA expression vectors and methods of use
AU2001284999B2 (en) 2000-08-14 2006-09-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modifications of HIV Env, Gag and Pol enhance immunogenicity for genetic immunization
DK1372710T3 (da) 2001-03-08 2010-01-18 Us Gov Health & Human Serv MVA der udtrykker modificeret HIV-kappe-, Gag- og Pol-gener
ATE458496T1 (de) * 2002-01-14 2010-03-15 Novartis Vaccines & Diagnostic Hiv-vakzine und anwendungsverfahren
US9783594B2 (en) 2011-05-17 2017-10-10 The Rockefeller University Human immunodeficiency virus neutralizing antibodies and methods of use thereof
US20150355178A1 (en) * 2012-09-04 2015-12-10 Mbio Diagnostics, Inc. System and method for improving biomarker assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells

Also Published As

Publication number Publication date
DK149589A (da) 1989-09-29
EP0335635A1 (en) 1989-10-04
JPH029372A (ja) 1990-01-12
DK149589D0 (da) 1989-03-28
AU3170089A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
IL89567A0 (en) Mutated hiv envelope protein
AU611639C (en) Bags
GB8817997D0 (en) Enzyme electrodes & improvements in manufacture thereof
EP0355247A3 (en) Compressed-molded preparations
AU1466188A (en) Bifunctional proteins
AU588068B2 (en) Sorting
AU5904986A (en) Sorting cutlery
AU574878B2 (en) Copolyester
GB2180250B (en) High strength copolyester
GB8804859D0 (en) Electrode & construction thereof
IL79579A0 (en) Copolyester
GB8817160D0 (en) Novel proteins
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
ZA899471B (en) An envelope
GB8611807D0 (en) Envelope
GB2195979B (en) Improved envelope
GB8808922D0 (en) Envelope
GB8816095D0 (en) Protein
GB8617026D0 (en) Envelope
GB8616649D0 (en) Envelope
GB8725462D0 (en) Protein
GB8725463D0 (en) Protein
GB8716969D0 (en) Envelopes
AU104880S (en) Envelope
CA59754S (en) Envelope